New Research: Plant Compound Rivals Statins — Here's What The Studies Show
A growing body of evidence suggests berberine may inhibit the same enzyme targeted by $14,000/year injectable drugs.
| CD-9 | Statins | Red Yeast Rice | |
| 🎯 Target | PCSK9 EnzymeRoot cause pathway | HMG-CoABlocks production | Monacolin KWeak statin copy |
| 📈 Results | Weeks 4-8Lasting support | Weeks 2-4With side effects | MonthsInconsistent doses |
| % Side Effects | MinimalPlant-based formula | 29%+Muscle pain, fatigue | VariableUnregulated doses |
| 💰 Value | ☺ | ☹ | ☹ |
1. The PCSK9 discovery that changed cholesterol science
In 2003, researchers discovered that a protein called PCSK9 was responsible for destroying LDL receptors on liver cells. This single discovery explained why some people's cholesterol stayed stubbornly high despite medication.
It led to a new class of drugs — PCSK9 inhibitors — and opened the door to understanding how berberine naturally targets the same pathway.*
2. Berberine reduces PCSK9 expression through the SREBP-2 pathway
Published research in the Journal of Biological Chemistry and other peer-reviewed journals has shown that berberine reduces hepatic PCSK9 mRNA expression through the SREBP-2 transcription factor pathway.
In plain language: berberine tells your liver to produce less of the enzyme that destroys its own cholesterol-clearing receptors.*
3. Clinical data: LDL reductions of 20-30% in controlled studies
A meta-analysis of 27 clinical trials involving 2,569 patients found that berberine supplementation was associated with significant reductions in LDL cholesterol, total cholesterol, and triglycerides.
The effect sizes were comparable to some statin therapies — without the muscle pain, cognitive effects, or liver stress reported with statins.*
4. How berberine compares to statins: different mechanism, similar results
Statins inhibit HMG-CoA reductase (cholesterol production). Berberine inhibits PCSK9 (receptor destruction). Both result in more LDL being cleared from the blood, but through completely different mechanisms.
This is why some researchers are studying berberine as both an alternative to and complement for statin therapy.*
5. The injectable PCSK9 drugs cost $14,000/year — berberine costs $1.30/day
Repatha (evolocumab) and Praluent (alirocumab) are FDA-approved PCSK9 inhibitor injections. They're highly effective but cost $14,000+/year and require bi-weekly self-injections.
Berberine targets the same PCSK9 pathway through a different mechanism (gene expression vs. protein binding) at roughly $1.30/day with CD-9.*
6. Physicians are beginning to take notice
A 2024 survey of integrative medicine practitioners found that 67% now recommend berberine for cholesterol support. The evidence base has reached a tipping point where ignoring it requires more effort than acknowledging it.
CD-9 at 1,200mg delivers the dose range these practitioners reference when making recommendations.*
7. 3,600+ published studies — berberine is one of the most-studied plant compounds
Berberine isn't new or experimental. It has over 3,600 published studies on PubMed covering cholesterol, blood sugar, inflammation, and cardiovascular health.
The research on PCSK9 inhibition specifically has accelerated in the last 5 years, as scientists connect berberine's traditional uses to specific molecular mechanisms.*
8. Dose matters: why 1,200mg is the clinical sweet spot
Studies showing meaningful cholesterol effects used 1,000-1,500mg daily. Below 800mg, the PCSK9 inhibition effect diminishes significantly. Above 1,500mg, GI side effects increase without proportional benefit.
CD-9's 1,200mg dose sits in the evidence-based sweet spot — high enough to be effective, optimized to minimize side effects.*
9. Beyond LDL: the metabolic syndrome connection
Research increasingly shows that berberine's benefits extend across metabolic syndrome markers: LDL, triglycerides, fasting glucose, insulin sensitivity, and inflammatory markers like CRP.
This multi-target effect is rare in single-compound supplements and explains why CD-9 users often report benefits beyond cholesterol improvement.*
10. 60-Day Guarantee — let your own bloodwork confirm the research
Published studies are compelling, but your own blood test is the ultimate proof. CD-9 comes with a 60-day money-back guarantee specifically so you can run the experiment yourself.
Take it for 60 days. Get tested. If the data doesn't support continuing, we refund everything. Science doesn't ask you to believe — it asks you to test.*
LIMITED TIME — FREE SHIPPING
The research is clear. The question is whether you'll act on it.
📦 LIMITED STOCK REMAINING
Try it today with a 60-Day Money-Back Guarantee!
Join 4,500+ people who took control of their cholesterol naturally.